The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Endothelial α ν β 3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis
Abstract
Objective— Angiogenic expansion of the vasa vasorum is a well-known feature of progressive atherosclerosis, suggesting that antiangiogenic therapies may stabilize or regress plaques. α ν β 3 Integrin–targeted paramagnetic nanoparticles were prepared for noninvasive assessment of angiogenesis in early atherosclerosis, for site-specific delivery of antiangiogenic drug, and for quantitative follow-up of response. Methods and Results— Expression of α ν β 3 integrin by vasa vasorum was imaged at 1.5 T in cholesterol-fed rabbit aortas using integrin-targeted paramagnetic nanoparticles that incorporated fumagillin at 0 μg/kg or 30 μg/kg. Both formulations produced similar MRI signal enhancement (16.7%±1.1%) when integrated across all aortic slices from the renal arteries to the diaphragm. Seven days after this single treatment, integrin-targeted paramagnetic nanoparticles were readministered and showed decreased MRI enhancement among fumagillin-treated rabbits (2.9%±1.6%) but not in untreated rabbits (18.1%±2.1%). In a third group of rabbits, nontargeted fumagillin nanoparticles did not alter vascular α ν β 3 -integrin expression (12.4%±0.9%; P >0.05) versus the no-drug control. In a second study focused on microscopic changes, fewer microvessels in the fumagillin-treated rabbit aorta were counted compared with control rabbits. Conclusions— This study illustrates the potential of combined molecular imaging and drug delivery with targeted nanoparticles to noninvasively define atherosclerotic burden, to deliver effective targeted drug at a fraction of previous levels, and to quantify local response to treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A team led by Wickline and Lanza107 has shown that a single injection of αVβ3 integrin-targeted paramagnetic nanoparticles for site-specific delivery of the anti-angiogenic drug fumagillin is enough to inhibit angiogenesis in a rabbit model.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“In a follow-up study the same group demonstrated that these nanoparticles decreased the burden of aortic angiogenesis for 3 weeks after treatment”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“and that this effect was prolonged when applied in combination with oral atorvastatin (Lipitor; Pfizer) administration.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“This was determined using αVβ3 integrin-specific MRI, thus representing a potential strategy for an anti-angiogenic therapeutic regimen107,108 (FIG. 3c).”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
In the citing paper
“This was the first study to show the therapeutic potential of combined molecular imaging and drug delivery with targeted nanoparticles in a rabbit model of atherosclerosis.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [107]
Citations
Cites
Guide to the care and use of experimental animals
Olfert, E. D. (1993) · Cited by 3,184
Intraplaque Hemorrhage and Progression of Coronary Atheroma
Kolodgie, F. D., Gold, H. K., BURKE, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., Farb, A. A., Guerrero, L. J., Hayase, M., Kutys, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035655 · Cited by 1,491
Atherosclerotic Plaque Progression and Vulnerability to Rupture
Virmani, R., Kolodgie, F. D., BURKE, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,326
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. (1998) · Nature Medicine · doi:10.1038/nm0598-623 · Cited by 843
Winter, P. M., Morawski, A. M., Caruthers, S. D., Fuhrhop, R. W., Zhang, H., Williams, T. A., Allen, J. S., Lacy, E. K., Robertson, J. D., Lanza, G. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093185.16083.95 · Cited by 696
Self-citationMoulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688
Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta
Moreno, P., Purushothaman, K., Fuster, V., Echeverri, D., Truszczynska, H., Sharma, S. K., Badimón, J. J., & O’Connor, W. N. (2004) · Circulation · doi:10.1161/01.cir.0000143233.87854.23 · Cited by 632
Flacke, S., Fischer, S., Scott, M. J., Fuhrhop, R. J., Allen, J. S., McLean, M., Winter, P., Sicard, G. A., Gaffney, P. J., Wickline, S. A., et al. (2001) · Circulation · doi:10.1161/hc3601.094303 · Cited by 515
Self-citationStructure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J. (1998) · Science · doi:10.1126/science.282.5392.1324 · Cited by 440
Winter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 375
Self-citation
Cited by
Sorted by citations
Items 101–200 of 378
Recent Advances in 19 Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
Schmieder, A. H., Caruthers, S. D., Keupp, J., Wickline, S. A., & Lanza, G. M. (2015) · Engineering · doi:10.15302/j-eng-2015103 · Cited by 67
Self-citationMolecular Imaging of Atherothrombotic Diseases
Wang, X., & Peter, K. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.306483 · Cited by 67
Nanotechnology applications for cardiovascular disease treatment: Current and future perspectives
Wang, D. K., Rahimi, M., & Filgueira, C. S. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102387 · Cited by 71
Recent advances on nanoparticle-based therapies for cardiovascular diseases
Soumya, R. S., & Raghu, K. G. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.02.009 · Cited by 68
Targeting therapeutics to endothelium: are we there yet?
Kiseleva, R. Y., Glassman, P. M., Greineder, C. F., Hood, E. D., Shuvaev, V. V., & Muzykantov, V. R. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0464-6 · Cited by 64
Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles
Snipstad, S., Westrøm, S., Mørch, Y. A., Afadzi, M., Åslund, A., & Davies, C. D. L. (2014) · Cancer Nanotechnology · doi:10.1186/s12645-014-0008-4 · Cited by 60
Nanoimmunotherapy to treat ischaemic heart disease
Duivenvoorden, R., Senders, M. L., van Leent, M. M. T., Pérez‐Medina, C., Nahrendorf, M., Fayad, Z. A., & Mulder, W. J. M. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0073-1 · Cited by 62
Nanomedical Applications of Nanoparticles for Blood Coagulation Disorders
Lateef, A., Ojo, S. A., Elegbede, J. A., Akinola, P. O., & Akanni, E. O. (2018) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-319-76090-2_8 · Cited by 60
Zhou, H.-F., Yan, H., Senpan, A., Wickline, S. A., Pan, D., Lanza, G. M., & Pham, C. T. N. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.005 · Cited by 61
Self-citationLi, T., Liang, W., Xiao, X., & Qian, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s179678 · Cited by 63
The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis
Zia, A., Wu, Y., Nguyen, T. A. H., Wang, X., Peter, K., & Ta, H. T. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa047 · Cited by 60
Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis
Zhang, X., Misra, S. K., Moitra, P., Zhang, X., Jeong, S., Stitham, J., Rodríguez-Vélez, A., Park, A. C., Yeh, Y., Gillanders, W. E., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2108252 · Cited by 65
Jacobin‐Valat, M., Deramchia, K., Mornet, S., Hagemeyer, C. E., Bonetto, S., Robert, R., Biran, M., Massot, P., Miraux, S., Sanchez, S., et al. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1606 · Cited by 60
Gold Nanorods Targeted to Delta Opioid Receptor: Plasmon-Resonant Contrast and Photothermal Agents
Black, K. C. L., Kirkpatrick, N. D., Troutman, T. S., Xu, L., Vágner, J., Gillies, R. J., Barton, J. K., Utzinger, U., & Romanowski, M. (2008) · Molecular Imaging · doi:10.2310/7290.2008.0007 · Cited by 60
Nanoplumbers: biomaterials to fight cardiovascular diseases
Dormont, F., Varna, M., & Couvreur, P. (2017) · Materials Today · doi:10.1016/j.mattod.2017.07.008 · Cited by 61
Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)
Huang, R. B., Mocherla, S., Heslinga, M. J., Charoenphol, P., & Eniola‐Adefeso, O. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.522117 · Cited by 64
Winter, P. M., Caruthers, S. D., Allen, J. S., Cai, K., Williams, T. A., Lanza, G. M., & Wickline, S. A. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22447 · Cited by 59
Self-citationRecent advances in colloidal gold nanobeacons for molecular photoacoustic imaging
Pan, D., Pramanik, M., Wickline, S. A., Wang, L. V., & Lanza, G. M. (2011) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.449 · Cited by 59
Self-citationApplying nanomedicine in maladaptive inflammation and angiogenesis
Alaarg, A., Pérez‐Medina, C., Metselaar, J. M., Nahrendorf, M., Fayad, Z. A., Storm, G., & Mulder, W. J. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.009 · Cited by 60
Nanomedical Theranostics in Cardiovascular Disease
Tang, J., Lobatto, M. E., Read, J. C., Mieszawska, A. J., Fayad, Z. A., & Mulder, W. J. M. (2011) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-011-9120-6 · Cited by 60
Nanomedicines for endothelial disorders
Chung, B. L., Toth, M. J., Kamaly, N., Sei, Y. J., Becraft, J. R., Mulder, W. J. M., Fayad, Z. A., Farokhzad, O. C., Kim, Y., & Langer, R. (2015) · Nano Today · doi:10.1016/j.nantod.2015.11.009 · Cited by 59
Kaneda, M. M., Sasaki, Y., Lanza, G. M., Milbrandt, J., & Wickline, S. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.006 · Cited by 57
Self-citationPan, D., Schmieder, A. H., Wang, K., Yang, X., Senpan, A., Cui, G., Killgore, K., Kim, B. B., Allen, J. S., Zhang, H., et al. (2014) · Theranostics · doi:10.7150/thno.7581 · Cited by 57
Self-citationThe Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases
Paluszkiewicz, P., Martuszewski, A., Zaręba, N., Wala, K., Banasik, M., & Kepinská, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010131 · Cited by 58
Yuan, Z., Liao, Y. S., Tian, G., Li, H., Jia, Y., Zhang, H., Tan, Z., Li, X., Deng, W., Liu, K., et al. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.08.066 · Cited by 56
Self-citationMolecular Imaging of Atherosclerosis with Nanoparticle-Based Fluorinated MRI Contrast Agents
Palekar, R. U., Jallouk, A. P., Lanza, G. M., Pan, H., & Wickline, S. A. (2015) · Nanomedicine · doi:10.2217/nnm.15.26 · Cited by 57
Self-citationInflammation and Neovascularization Intertwined in Atherosclerosis
Sadat, U., Jaffer, F. A., van Zandvoort, M. A. M. J., Nicholls, S. J., Ribatti, D., & Gillard, J. H. (2014) · Circulation · doi:10.1161/circulationaha.114.010369 · Cited by 55
Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles
Wang, S., He, H., Mao, Y., Zhang, Y., & Gu, N. (2024) · Advanced Science · doi:10.1002/advs.202308298 · Cited by 59
Zhang, R., Pan, D., Cai, X., Yang, X., Senpan, A., Allen, J. S., Lanza, G. M., & Wang, L. V. (2014) · Theranostics · doi:10.7150/thno.10014 · Cited by 56
Self-citationCD44 Targeting Magnetic Glyconanoparticles for Atherosclerotic Plaque Imaging
El‐Dakdouki, M. H., El‐Boubbou, K., Kamat, M. N., Huang, R., Abela, G. S., Kiupel, M., Zhu, D. C., & Huang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1021-8 · Cited by 55
Neto, D. M. A., Freire, R. M., Gallo, J., Freire, T. M., de Queiroz, D. C., Ricardo, N. M. P. S., Vasconcelos, I. F., Mele, G., Carbone, L., Mazzetto, S. E., et al. (2017) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.7b04941 · Cited by 57
Multimodality nanotracers for cardiovascular applications
Mulder, W. J. M., Cormode, D. P., Hak, S., Lobatto, M. E., Silvera, S., & Fayad, Z. A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1242 · Cited by 54
Calcagno, C., Mani, V., Ramachandran, S., & Fayad, Z. A. (2010) · Angiogenesis · doi:10.1007/s10456-010-9172-2 · Cited by 52
Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
Zhang, S., Xu, W., Gao, P., Chen, W., & Zhou, Q. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1699823 · Cited by 52
Anti‐angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis
Caruthers, S. D., Cyrus, T., Winter, P. M., Wickline, S. A., & Lanza, G. M. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.9 · Cited by 49
Self-citationMutually Supportive Mechanisms of Inflammation and Vascular Remodeling
Whiteford, J. R., Rossi, G. D., & Woodfin, A. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.001 · Cited by 48
Su, T., Wang, Y., Han, D. H., Wang, J., Qi, S., Gao, L., Shao, Y., Qiao, H., Chen, J., Liang, S., et al. (2017) · Theranostics · doi:10.7150/thno.20767 · Cited by 48
Akers, W. J., Zhang, Z., Березин, М. Б., Ye, Y., Agee, A., Guo, K., Fuhrhop, R. W., Wickline, S. A., Lanza, G. M., & Achilefu, S. A. (2010) · Nanomedicine · doi:10.2217/nnm.10.38 · Cited by 47
Self-citationTheranostic Nanoparticles for Cancer and Cardiovascular Applications
Wang, D., Lin, B., & Ai, H. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1277-z · Cited by 45
MnO-Labeled Cells: Positive Contrast Enhancement in MRI
Létourneau, M., Tremblay, M., Faucher, L., Rojas, D., Chevallier, P., Gossuin, Y., Lagueux, J., & Fortin, M. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp3032918 · Cited by 45
Jiang, F., Tian, S., Lu, J., Ding, X., Qian, C., Ding, B., Ding, Z., & Jin, B. (2015) · BioMed Research International · doi:10.1155/2015/501581 · Cited by 45
Angiogenesis is required for stress fracture healing in rats
Tomlinson, R. E., McKenzie, J. A., Schmieder, A. H., Wohl, G. R., Lanza, G. M., & Silva, M. J. (2012) · Bone · doi:10.1016/j.bone.2012.09.035 · Cited by 45
Self-citationPerfluorocarbon Nanoparticles for Physiological and Molecular Imaging and Therapy
Chen, J., Pan, H., Lanza, G. M., & Wickline, S. A. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.08.004 · Cited by 44
Self-citationNanomedicine in coronary artery disease
Ambesh, P., Campia, U., Obiagwu, C., Bansal, R., Shetty, V., Hollander, G. M., & Shani, J. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.02.007 · Cited by 43
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
Psarros, C. T., Lee, R., Margaritis, M., & Antoniades, C. A. (2012) · Maturitas · doi:10.1016/j.maturitas.2011.12.014 · Cited by 43
An elastase-inhibiting, plaque-targeting and neutrophil-hitchhiking liposome against atherosclerosis
Shi, Y., Dong, M., Wu, Y., Gong, F., Wang, Z., Xue, L., & Su, Z. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.11.020 · Cited by 44
Schmieder, A. H., Winter, P. M., Williams, T. A., Allen, J. S., Hu, G., Zhang, H., Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2013) · Radiology · doi:10.1148/radiol.13120789 · Cited by 41
Self-citationNano-medicine and Vascular Endothelial Dysfunction: Options and Delivery Strategies
Taneja, G., Sud, A., Pendse, N., Panigrahi, B. P., Kumar, A., & Sharma, A. K. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9491-x · Cited by 44
Convergence of Nanotechnology and Cardiovascular Medicine
Iverson, N. M., Plourde, N. M., Chnari, E., Nackman, G. B., & Moghe, P. V. (2008) · BioDrugs · doi:10.2165/00063030-200822010-00001 · Cited by 41
Current Advances in Nanotheranostics for Molecular Imaging and Therapy of Cardiovascular Disorders
Setia, A., Mehata, A. K., Priya, V., Pawde, D. M., Jain, D., Mahto, S. K., & Muthu, M. S. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00582 · Cited by 42
Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features
Stendahl, J. C., & Sinusas, A. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160994 · Cited by 38
SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides
Yoo, J. S., Lee, J., Jung, J. H., Moon, B. S., Kim, S., Lee, B. C., & Kim, S. E. (2015) · Scientific Reports · doi:10.1038/srep11752 · Cited by 42
Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery
Li, X., Sui, Z., Li, X., Xu, W., Guo, Q., Sun, J., & Jing, F. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s164905 · Cited by 40
In Vivo Fate of Avidin-Nucleic Acid Nanoassemblies as Multifunctional Diagnostic Tools
Bigini, P., Previdi, S., Casarin, E., Silvestri, D., Violatto, M. B., Facchin, S., Sitia, L., Rosato, A., Zuccolotto, G., Realdon, N., et al. (2013) · ACS Nano · doi:10.1021/nn402669w · Cited by 39
Nanomedicine for respiratory diseases
Swai, H., Semete‐Makokotlela, B., Kalombo, L., Chelule, P. K., Kisich, K. O., & Sievers, B. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.33 · Cited by 39
The Therapeutic Potential of Nanoparticles to Reduce Inflammation in Atherosclerosis
Gorabi, A. M., Kiaie, N., Reiner, Ž., Carbone, F., Montecucco, F., & Sahebkar, A. (2019) · Biomolecules · doi:10.3390/biom9090416 · Cited by 40
Pan, D., Pham, C. T. N., Weilbaecher, K. N., Tomasson, M. H., Wickline, S. A., & Lanza, G. M. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1355 · Cited by 39
Self-citationTargeted Probes for Cardiovascular MRI
Uppal, R., & Caravan, P. D. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.09.154 · Cited by 38
Beilvert, A., Cormode, D. P., Chaubet, F., Briley-Saebo, K. C., Mani, V., Mulder, W. J. M., Vucic, E., Toussaint, J., Letourneur, D., & Fayad, Z. A. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22103 · Cited by 38
Xu, X., Mao, W., Chai, Y., Dai, J., Chen, Q., Wang, L., Zhuang, Q., Pan, Y., Chen, M., Gui-bao, N., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.26906 · Cited by 38
Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis
Prilepskii, A. Y., Serov, N., Kladko, D. V., & Vinogradov, V. V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111056 · Cited by 38
Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis
Chistiakov, D. A., Melnichenko, A. А., Myasoedova, V. A., Grechko, A. V., & Orekhov, A. N. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1366041 · Cited by 37
Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers
Tan, K. X., Pan, S., Jeevanandam, J., & Danquah, M. K. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.023 · Cited by 37
Manners, N., Priya, V., Mehata, A. K., Rawat, M., Mohan, S., Makeen, H. A., Albratty, M., Albarrati, A., Meraya, A. M., & Muthu, M. S. (2022) · Pharmaceuticals · doi:10.3390/ph15040441 · Cited by 40
Boles, K. S., Schmieder, A. H., Koch, A. W., Carano, R. A. D., Wu, Y., Caruthers, S. D., Tong, R. K., Stawicki, S. S., Hu, G., Scott, M. J., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-157933 · Cited by 36
Self-citationInsights into Atherosclerosis Using Nanotechnology
Jayagopal, A., Linton, M. F., Fazio, S., & Haselton, F. R. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0106-7 · Cited by 36
Current status of nanotechnology approaches for cardiovascular disease: a personal perspective
Buxton, D. B. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.8 · Cited by 34
Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures
Pan, H., Myerson, J. W., Ivashyna, O., Soman, N. R., Marsh, J. N., Hood, J. L., Lanza, G. M., Schlesinger, P. H., & Wickline, S. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-153130 · Cited by 34
Self-citationSaraste, A., Laitinen, I., Weidl, E., Wildgruber, M., Weber, A. W., Nekolla, S. G., Hölzlwimmer, G., Esposito, I., Walch, A. K., Leppänen, P., et al. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9554-5 · Cited by 33
MR Molecular Imaging of Aortic Angiogenesis
Cai, K., Caruthers, S. D., Huang, W., Williams, T. A., Zhang, H., Wickline, S. A., Lanza, G. M., & Winter, P. M. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.03.012 · Cited by 33
Self-citationSharma, G., She, Z., Valenta, D. T., Stallcup, W. B., & Smith, J. W. (2010) · Nano LIFE · doi:10.1142/s1793984410000183 · Cited by 33
Nanomedicine Captures Cardiovascular Disease
Mulder, W. J. M., & Fayad, Z. A. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165332 · Cited by 34
van Bochove, G. S., Paulis, L. E. M., Segers, D., Mulder, W. J. M., Krams, R., Nicolay, K., & Strijkers, G. J. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.402 · Cited by 33
Antiangiogenic Nanotherapy with Lipase-Labile Sn-2 Fumagillin Prodrug
Pan, D., Sanyal, N., Schmieder, A. H., Senpan, A., Kim, B. B., Yang, X., Hu, G., Allen, J. S., Gross, R. W., Wickline, S. A., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.27 · Cited by 32
Self-citationRecent strategies to design vascular theranostic nanoparticles
Gupta, M. K., Lee, Y., Boire, T. C., Lee, J.-B., Kim, W. S., & Sung, H. (2017) · Nanotheranostics · doi:10.7150/ntno.18531 · Cited by 32
Li, X., Hou, L., Yang, L., Mo, L., Li, L., & Qin, F. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s67343 · Cited by 31
Pan, H., Palekar, R. U., Hou, K. K., Bacon, J., Yan, H., Springer, L. E., Akk, A. M., Yang, L., Miller, M. J., Pham, C. T. N., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168556 · Cited by 32
Self-citationNanoparticle theranostics in cardiovascular inflammation
MacRitchie, N. A., Francesco, V. D., Ferreira, M. F. M. M., Guzik, T. J., Decuzzi, P., & Maffia, P. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101536 · Cited by 32
Montelione, N., Loreni, F., Nenna, A., Catanese, V., Scurto, L., Ferrisi, C., Jawabra, M., Gabellini, T., Codispoti, F. A., Spinelli, F., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11030798 · Cited by 30
Molecular MRI of Atherosclerosis
Phinikaridou, A., Andía, M. E., Lacerda, S., Lorrio, S., Makowski, M. R., & Botnar, R. M. (2013) · Molecules · doi:10.3390/molecules181114042 · Cited by 30
Engineering Nanomaterials to Address Cell-Mediated Inflammation in Atherosclerosis
Allen, S. D., Liu, Y., & Scott, E. A. (2016) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-016-0012-9 · Cited by 32
Anwaier, G., Chen, C., Cao, Y., & Qi, R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s142385 · Cited by 30
Therapeutic strategies to deplete macrophages in atherosclerotic plaques
Meyer, I. D., Martinet, W., & Meyer, G. R. Y. D. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04211.x · Cited by 31
Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis
Calcagno, C., Ramachandran, S., Millon, A., Robson, P. M., Mani, V., & Fayad, Z. A. (2012) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-012-9177-x · Cited by 30
Nanomedicine applications in women's health: state of the art
Lloyd-Parry, O., Downing, C., Aleisaei, E., Jones, C., & Coward, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s97572 · Cited by 31
Hoseinzadeh, A., Johari, H. G., Anbardar, M. H., Tayebi, L., Vafa, E., Abbasi, M., Vaez, A., Golchin, A., Amani, A. M., & Jangjou, A. (2022) · European journal of medical research · doi:10.1186/s40001-022-00833-6 · Cited by 30
Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque
Canet‐Soulas, E., & Letourneur, D. (2007) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-007-0078-y · Cited by 29
Imaging of apoptosis in the heart with nanoparticle technology
Chen, H. H., Josephson, L., & Sosnovik, D. E. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.115 · Cited by 29
MR-optical imaging of cardiovascular molecular targets
Nahrendorf, M., Sosnovik, D. E., & Weissleder, R. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0707-2 · Cited by 29
Nanoparticles for Detection and Treatment of Peripheral Arterial Disease
Noukeu, L. C., Wolf, J., Yuan, B., Banerjee, S., & Nguyen, K. T. (2018) · Small · doi:10.1002/smll.201800644 · Cited by 28
Nanoimaging in cardiovascular diseases: Current state of the art
Deb, S., Ghosh, K., & Shetty, S. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.156557 · Cited by 28
Kanwar, R. K., Chaudhary, R., Tsuzuki, T., & Kanwar, J. R. (2012) · Nanomedicine · doi:10.2217/nnm.12.57 · Cited by 27
Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
Aprotosoaie, A. C., Costache, A. D., & Costache, I. I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040722 · Cited by 29
Molecular Imaging in Cardiovascular Magnetic Resonance Imaging
Sosnovik, D. E. (2008) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e318176c57b · Cited by 26
Magnetic Resonance Molecular Imaging Contrast Agents and Their Application in Atherosclerosis
Mulder, W. J. M., Strijkers, G. J., Vucic, E., Cormode, D. P., Nicolay, K., & Fayad, Z. A. (2007) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e31815a0e7f · Cited by 27
Standardization of Models and Methods Used to Assess Nanoparticles in Cardiovascular Applications
Fitzgerald, K. T., Holladay, C. A., McCarthy, C., Power, K. A., Pandit, A., & Gallagher, W. M. (2011) · Small · doi:10.1002/smll.201001347 · Cited by 26
Su, C., Lu, Y., Wang, Z., Guo, J., Hou, Y., Wang, X., Qin, Z., Gao, J., Sun, Z., Dai, Y., et al. (2022) · Aging and Disease · doi:10.14336/ad.2022.1208 · Cited by 28
Rationale for a Nanomedicine Approach to Thrombolytic Therapy
Lanza, G. M., Marsh, J. N., Hu, G., Scott, M. J., Schmieder, A. H., Caruthers, S. D., Pan, D., & Wickline, S. A. (2010) · Stroke · doi:10.1161/strokeaha.110.598656 · Cited by 26
Self-citationClinical Perspectives of Hybrid Proton-Fluorine Magnetic Resonance Imaging and Spectroscopy
Wolters, M., Mohades, S. G., Hackeng, T. M., Post, M. J., Kooi, M. E., & Backes, W. H. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e318277528c · Cited by 26
Soman, N. R., Marsh, J. N., Lanza, G., & Wickline, S. A. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/18/185102 · Cited by 25
Self-citation
Metadata
- Authors
- Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., Zhang, H., Wickline, S. A., & Lanza, G. M.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2006-09
- Volume
- 26
- Issue
- 9
- Pages
- 2103-2109
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2112285684
- Cited by
- 379
- References
- 31
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 15 · 2021: 16 · 2020: 13 · 2019: 17 · 2018: 14 · 2017: 23 · 2016: 12 · 2015: 22 · 2014: 29 · 2013: 17 · 2012: 37
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL073646, HL-73646, R01HL078631, HL 78631)
- National Cancer Institute (N01 CO 37007)
- National Institute of Biomedical Imaging and Bioengineering (R01EB001704, EB-01704)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Keywords
- alpha v beta 3 integrin, fumagillin, targeted nanoparticles, angiogenesis inhibition, atherosclerosis, vasa vasorum, paramagnetic nanoparticles, magnetic resonance imaging, molecular imaging, targeted drug delivery, atherosclerotic plaque, rabbit aorta
- MeSH terms
- Animals, Aorta, Abdominal, Cyclohexanes, Endothelium, Vascular, Fatty Acids, Unsaturated, Hyperlipidemias, Magnetic Resonance Imaging, Neovascularization, Pathologic, Rabbits, Sesquiterpenes, Drug Delivery Systems, Angiogenesis Inhibitors, Integrin alphaVbeta3, Nanostructures, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
